Queen Mary University Of London
Clinical trials sponsored by Queen Mary University Of London, explained in plain language.
-
Gentle gum therapy could heal bone defects without surgery
Disease control TerminatedThis study tests a minimally-invasive non-surgical therapy (MINST) for treating gum disease-related bone defects. The approach uses small instruments and magnification to clean deep gum pockets with less tissue damage than traditional surgery. Researchers will measure bone healin…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise in High-Risk breast cancer trial
Disease control OngoingThis study tests whether adding the drug ipatasertib to standard chemotherapy and immunotherapy (atezolizumab) can improve outcomes for women with high-risk triple-negative breast cancer before surgery. About 146 women with newly diagnosed, non-metastatic tumors that are at least…
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New valve implant offers hope for rare heart condition
Disease control OngoingThis study is testing a custom-made artificial heart valve, called TRICENTO, in 15 people with carcinoid heart disease who have severe leakage of the tricuspid valve and cannot have surgery. The valve is delivered through a catheter, avoiding open-heart surgery. The goal is to se…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could antibiotics save malnourished kids after hospital?
Disease control OngoingSevere acute malnutrition affects millions of children worldwide and often leads to death after hospital discharge. This phase 3 trial tests whether giving a combination of antibiotics (rifampicin, azithromycin, isoniazid, and vitamin B6) for several weeks can lower the risk of d…
Phase: PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Old drug, new hope: ATRA combo targets tough pancreatic cancer
Disease control OngoingThis phase IIb trial tests whether adding ATRA (a vitamin A derivative) to standard chemotherapy (gemcitabine and nab-paclitaxel) can help people with locally advanced pancreatic cancer live longer without their cancer growing. About 170 participants will receive either the combo…
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Second chance for hepatitis c cure: new trial tests best retreatment
Disease control ENROLLING_BY_INVITATIONThis study is for people in Pakistan with hepatitis C who did not get cured by their first treatment. It compares two different lengths of treatment with the drug Epclusa (12 weeks vs 24 weeks) to see which works better. About 318 adults will take part, and the goal is to find th…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a short pill course save hand function in advanced MS?
Disease control OngoingThis UK trial tests whether cladribine tablets, taken for just 8-10 days a year over two years, can slow the loss of hand function in people with advanced multiple sclerosis (MS). The study includes 204 participants with significant disability (EDSS 6.5-8.5). Half receive cladrib…
Phase: PHASE2, PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 26, 2026 15:20 UTC
-
New urine test could spot deadly pancreatic cancer sooner
Diagnosis OngoingThis study is working on a new way to detect pancreatic cancer early using a simple urine and blood test. Researchers are collecting samples from 3500 people, both with and without pancreatic disease, to see if a panel of biomarkers can accurately identify cancer. The goal is to …
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Could a simple blood test revolutionize dormant TB detection?
Diagnosis ENROLLING_BY_INVITATIONThis study evaluates a new blood test that aims to directly detect the bacteria causing dormant tuberculosis (TB), rather than relying on the body's immune response. Current tests cannot tell if treatment worked or who will develop active TB, leading to unnecessary antibiotics. R…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
New DNA blood test could speed up heart infection diagnosis
Diagnosis OngoingThis study tests a new blood test that looks for bacterial DNA to quickly identify the germ causing infective endocarditis, a serious heart valve infection. Current methods take up to 5 days, delaying the right antibiotics. The study will enroll 200 adults with suspected endocard…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
New wearable device could replace blood tests during surgery recovery
Knowledge-focused OngoingThis study tests a wearable device that continuously measures lactate levels in the fluid just under the skin. Researchers want to see if it matches standard blood tests in patients recovering from heart bypass or valve surgery. If it works, the device could make recovery more co…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could a skin blister test lead to a treatment for 'Drowning from the Inside'?
Knowledge-focused OngoingThis study tests whether a drug called racecadotril can reduce fluid leakage in skin blisters, as a model for what happens in the lungs during Acute Respiratory Distress Syndrome (ARDS). ARDS is a severe lung injury with no effective drug treatments, where patients' lungs fill wi…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Can a 'Learning health System' help thailand tackle its chronic disease crisis?
Knowledge-focused OngoingThis study tests whether a Learning Health System (LHS) can improve care for people with high blood pressure, diabetes, and kidney disease in Thai primary care clinics. The LHS uses electronic health records to help healthcare teams identify patients who need more active manageme…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
AI trained to predict which skin cancers will spread
Knowledge-focused OngoingThis study tests a computer model that uses deep learning to analyze tissue samples from 300 people with a common skin cancer called squamous cell carcinoma. The goal is to see if the model can predict whether the cancer will spread to other parts of the body. No new drugs or tre…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New patch could replace needles for monitoring heart patients
Knowledge-focused OngoingThis study tests a new sensor worn on the skin that measures lactate levels without needles. It involves 20 adults recovering from heart bypass or valve surgery. The goal is to see if the sensor works as well as standard blood tests, which could make monitoring more comfortable a…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Could At-Home HPV tests improve screening for transgender people?
Knowledge-focused OngoingThis study explores whether transgender individuals can collect their own samples for HPV testing at home or in a clinic. Researchers want to learn how common high-risk HPV is in this group and whether self-sampling is acceptable and effective. About 100 transgender men and women…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can we predict prostate Cancer's next move? researchers dig into decades of data
Knowledge-focused OngoingThis study analyzes medical records and biopsy samples from 3,350 men diagnosed with localized prostate cancer between 1990 and 2006. The goal is to identify biological, pathological, and clinical markers that can predict how the disease will progress. By understanding these fact…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC